Co-Diagnostics, Inc. Common Stock (CODX) support and resistance · rev $3.9M
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
This page maps Co-Diagnostics, Inc. Common Stock (CODX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
CODX currently screens at market cap $31.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CODX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CODX quote page for the session range and the stock page for the full model.
Not investment advice.